TrialACS infectious diseases2019

Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy.

Bryna L Fitzgerald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.